Literature DB >> 29384224

Curcumin on the "flying carpets" to modulate different signal transduction cascades in cancers: Next-generation approach to bridge translational gaps.

Hulya Celik1, Tuba Aydin2, Kubra Solak3, Sumbul Khalid4, Ammad A Farooqi5.   

Abstract

Curcumin, a bioactive and pharmacologically efficient component isolated from Curcuma longa has attracted considerable attention because of its ability to modulate diverse cellular and physiological pathways. WNT, TGF/SMAD, NOTCH, and SHH are fundamentally different signaling cascades, but their choreographed activation is strongly associated with cancer development and progression. In this review we have attempted to set spotlight on regulation of different cell signaling pathways by curcumin in different cancers. We partition this multi-component review into in-depth biological understanding of various signal transduction cascades and how curcumin targets intracellular signal transducers of deregulated pathways to inhibit cancer development and progression. Rapidly broadening landscape of both established and candidate oncogenic driver mutations identified in different cancers is a major stumbling block in the standardization of drugs having significant clinical outcome. Intra and inter-tumor heterogeneity had leveraged the complexity of therapeutic challenges to another level. Multi-pronged approach and molecularly guided treatments will be helpful in improving the clinical outcome.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  anticancer mechanism; apoptosis; curcumin; multifunctional properties; signaling cascades; therapy

Mesh:

Substances:

Year:  2018        PMID: 29384224     DOI: 10.1002/jcb.26749

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules in vitro.

Authors:  Liang Wang; Shixia Zhu; Chunpeng Zou; Hongju Kou; Maosheng Xu; Jie Li
Journal:  Heliyon       Date:  2022-07-11

Review 2.  Naturally occurring compounds as pancreatic cancer therapeutics.

Authors:  Ines Lohse; Erin Wildermuth; Shaun P Brothers
Journal:  Oncotarget       Date:  2018-10-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.